Restrictions and Mandatory Procedures for Entry into the Destinations

The SATA Group airlines have been permanently monitoring the national and international developments related to the Covid-19 outbreak and have complied with all the recommendations issued by the competent national and international entities, namely IATA (International Air Transport Association), the World Health Organization (WHO), the European Centre of Disease Prevention and Control, as well as the National and Regional Directorate of Health and also the national aeronautical entity, ANAC.

Click here for IATA recommendations on restrictions and entry procedures at destinations.

Need a temporary exemption to submitting a complete COVID-19 vaccination plan for travel out of Canada?
More information here.

 

Select your destination:

 

 

 

 

Restrictions and prevention measures applied by the authorities

Travel from domestic territory

There are currently no restrictions for all passengers traveling to the Azores on domestic flights (departing from national territory).

 

Travel from abroad

1. Passengers traveling to the Autonomous Region of the Azores on direct international flights must present, before boarding:

  1. Proof of a negative result of a molecular test (PCR) for SARS-CoV-2 infection, performed within 72 hours before boarding; or
     
  2. Proof of a negative result of a rapid antigen test (RAT) for SARS-CoV-2 infection, performed within 24 hours before boarding.

     

2. The following are exempt from the requirement to present a screening test for SARS-CoV-2 before boarding.
 

  1. Passengers who present a valid European Union COVID digital vaccination certificate or an International Vaccination Certificate from the World Health Organization;
     
  2. Passengers who present a vaccination certificate attesting to the completion of the holder's primary vaccination series, more than 14 and less than 270 days since the last dose, with a market-authorized COVID-19 vaccine, or the completion of a booster dose of a market-authorized COVID-19 vaccine. To be duly recognized, it must contain the following minimum required information:
     
    1. First name(s) and surname(s) of the holder;
    2. Date of birth;
    3. Disease or agent targeted: COVID-19 (SARS-CoV-2 or one of its variants);
    4. COVID-19 vaccine or prophylaxis;
    5. Name of the vaccine against COVID-19;
    6. Marketing authorization holder or manufacturer of the vaccine against COVID-19;
    7. The number in a series of doses and the total number of doses in the series;
    8. Date of vaccination, indicating the date of the last dose administered;
    9. Country where the vaccine was administered;
    10. The entity issuing the certificate.
       
  3. Passengers who present a valid European Union COVID digital test certificate, either digitally or on paper;
     
  4. Passengers presenting the valid European Union COVID digital recovery certificate with its QR code, or a declaration of clinical discharge from surveillance and prophylactic isolation measures issued by the public health service regarding SARS-CoV-2, which is valid for 180 days;
     
  5. Passengers aged 12 years and under;
     
  6. Health professionals on duty for transferring or evacuating patients with an updated professional periodic screening, under the technical standard of the Regional Health Authority in effect at the date of travel;
     
  7. Passengers with a disease duly confirmed by a medical statement attesting to anatomical and/or clinical incompatibility for conducting a SARS-CoV-2 diagnostic test through nasopharynx swab. In this case, passengers must submit, at least five working days before their trip, the mentioned declaration to the Regional Health Authority for validation, without prejudice to conducting a serological test upon arrival in the Azores;
     
  8. Airline crews that do not move from the airside to the landside of the airport, as well as those who travel in service outside the Azores and return without having left the aircraft.
     

2.1. These exception declarations may only be submitted in paper or digital form, excluding SMS format.
 

3. The document issued by the laboratory that performs the SARS-CoV-2 diagnostic test must include, in English or Portuguese, the following information:

  • passenger’s identification;
  • the name of the laboratory where the test was performed with mention to its certification;
  • the reference to the use of the accepted methodologies (PCR or RAT);
  • the reference to “nasopharyngeal or oropharyngeal swab” sample, “nasopharyngeal or oropharyngeal exudate”, “respiratory sample” or “respiratory exudate”;
  • the test date; and
  • its NEGATIVE result.
     

4. All passengers must comply with the rules on wearing a mask, physical distance, and respiratory hygiene set by the regional health authority.

 

This information is summarized and constantly updated, not exempting the full reading of the Official Entities website, available here.

Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

Top

 

Restrictions and prevention measures applied by the authorities

1. There are currently no restrictions for passengers entering the Autonomous Region of Madeira. However, all visitors aged 5 years or older who wish to access or attend any activity in the community, including visits, restaurants, bars and similar, discos, gyms, sports activities, and other cultural, social, recreational, and similar activities, must have the vaccination scheme started or completed or present a Recovery Certificate.
 

1.1. If the visitor is not vaccinated, a rapid antigen test (RAT) to screen for SARS-CoV-2 infection is required and must be performed weekly at the visitor's expense.
 

1.2. Visitors who cannot be vaccinated are exempt, upon presentation of a formal medical declaration.
 

2. The use of a surgical or FFP mask2 by persons aged 6 years and older is mandatory for accessing or staying on the following premises:

  1. In healthcare facilities and services, including community pharmacies;
  2. In residential or reception facilities or home support services for vulnerable populations, elderly or disabled people, as well as integrated continued care units of the Integrated Continued Care Network of the Autonomous Region of Madeira;
  3. In the use of collective passenger transport, including airplanes, as well as in the transport of passengers in Taxicabs or similar;
  4. On platforms and covered accesses to public transportation, including airports and maritime terminals;
  5. In confirmed cases of COVID-19, in all circumstances, whenever they are out of their isolation site until the 10th day after the date of onset of symptoms or positive test.
     

2.1. The obligation to wear a mask is waived in the following situations:

  1. Upon presentation of a medical statement certifying that the person's clinical condition is inconsistent with the use of a mask;
  2. When the use of a mask is incompatible with the activities that people are performing, such exemption should be limited to the strictly necessary.
     

2.2. The use of masks is recommended in the following contexts:

  1. By vulnerable persons, namely persons with chronic diseases or states of immunosuppression at increased risk for severe COVID-19, whenever at increased risk of exposure;
  2. By persons in contact with more vulnerable persons;
  3. By any person over 6 years old whenever in crowded, closed environments.
     

3. Visitors who are or become infected with SARS-CoV-2, with symptoms, and sick with COVID-19 should be confined for five days in the home or hotel where they are staying, at their own expense, returning to the community on the 6th day if they are symptom-free, without the need for a rapid antigen test (TRAg) to screen for SARS-CoV-2 infection.
 

3.1. Asymptomatic visitors with positive result from the RAT test for SARS-CoV-2 infection do not require isolation, but must wear masks to access, circulate or remain indoors and outdoors, in all activities of daily life, and may not visit establishments belonging to the health, social, education and civil protection sectors for a period of five days.
 

4. Visitors, regardless of their vaccination status, with a body temperature of 38 °C or higher, are entitled to a free rapid antigen test (RAT) to screen for SARS-CoV-2 infection, to be performed at the entities that signed the protocol with the Regional Government (ANF and ACIF).
 

5. Visitors are recommended to comply with sanitary rules in enclosed spaces, namely hand hygiene and respiratory etiquette.
 

6. Visitors are recommended to use the app S-Alerta Cidadão, so that their self-management of care continues to contribute to the monitoring of the pandemic in the Autonomous Region of Madeira, in collaboration with the health authorities.

 

These guidelines do not exempt the careful reading of the Regional Government Council Resolution No. 316/2022 of May 13, 2022.

This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.

Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.
 

 

Top

 

 

Restrictions and prevention measures applied by the authorities


1. All passengers on flights to or transiting mainland Portugal must present one of the following documents to the airline before boarding, without which they may not board:
 

  1. Proof of a laboratory nucleic acid amplification test (NAT) for screening for SARS-CoV-2 infection, with a negative result, performed within 72 hours before departure; or
     
  2. Proof of a rapid antigen test (RAT) of professional use for screening for SARS-CoV-2 infection, with a negative result, carried out within 24 hours before departure; or
     
  3. The EU Digital COVID Certificate in the form of vaccination, recovery, or test certificate, as provided in point 2 below; or
     
  4. Recognized certificates of vaccination or recovery issued by third countries under conditions of reciprocity that meet the requirements indicated in point 2 below. Note: the COVID-19 vaccination record cards are not accepted.
     

1.1. The proof of laboratory performance of the rapid antigen test (RAT) must contain the standard data set defined by the European Union Health Security Committee. Only tests from the general list of rapid antigen tests for Covid-19 screening within the European Union agreed by this Health Security Committee are allowed.
 

1.2. The following are exempted from the requirement of presenting, before boarding, proof of a laboratory nucleic acid amplification test (NAAT) or rapid antigen test (RAT) for screening for SARS-CoV-2 infection with negative results, carried out within 72 or 24 hours before departure, respectively:
 

  1. Children who have not yet reached 12 years of age;
     
  2. Passengers who are national citizens, foreign citizens with legal residence in mainland Portugal or diplomatic personnel stationed in Portugal on flights originating in the autonomous regions of the Azores and Madeira. However, if their departure to mainland Portugal is to transfer to another country, passengers will have to comply with the destination country's procedures.
     

1.3. Passengers with Portuguese citizenship and foreign passengers legally residing in mainland Portugal, as well as diplomatic personnel stationed in Portugal who, exceptionally, do not have proof of a negative test result, when required, are allowed to perform, on arrival, before entering mainland Portugal, at their own expense, a nucleic acid amplification test (NAAT) or rapid antigen test (RAT), and, to this end, will be forwarded by the competent authorities, waiting in a dedicated location within the airport until notification of the result.
 

2. The following certificates are accepted:

  1. Vaccination certificate attesting:
     
    1. The completion of the holder's primary vaccination series, more than 14 days and less than 270 days since the last dose, with a market-authorized COVID-19 vaccine; or
    2. The completion of a booster dose of a market-authorized COVID-19 vaccine.
       
  2. Test certificate, attesting that the holder has been subjected to:
     
    1. a nucleic acid amplification molecular test (NAAT), within the last 72 hours, with a negative result;
    2. a rapid antigen test within the last 24 hours, with a negative result;
       
  3. A certificate of recovery, certifying that the holder has recovered from SARS-CoV-2 infection, following a positive NAAT test result, for more than 11 days and less than 180 days.
     

2.1. The vaccination program is considered complete after the administration:

  1. From a single dose of a COVID-19 vaccine with a one-dose vaccination program;
  2. Of the second dose of a COVID-19 vaccine with a two-dose vaccination schedule, even if doses of two distinct vaccines have been administered; or
  3. Of the first dose of a COVID-19 vaccine with a two-dose vaccination schedule by persons who have recovered from the disease, stating on the vaccination certificate that the vaccination schedule was completed after administration of one dose.
     

2.2. A ''booster dose'' refers to a dose of a COVID-19 vaccine given after completion of a primary vaccination series as defined in the previous paragraph.
 

2.3. Vaccination certificates, to be duly recognized, must include, at least, the following information:

  1. First name(s) and surname(s) of the holder;
     
  2. Date of birth;
     
  3. Disease or agent targeted: COVID-19 (SARS-CoV-2 or one of its variants);
     
  4. COVID-19 vaccine or prophylaxis;
     
  5. Name of the vaccine against COVID-19;
     
  6. Marketing authorization holder or manufacturer of the vaccine against COVID-19;
     
  7. The number in a series of doses and the total number of doses in the series;
     
  8. Date of vaccination, indicating the date of the last dose administered;
     
  9. Member State or third country where the vaccine was administered;
     
  10. The entity issuing the certificate.
     

2.4. Recovery certificates, to be duly recognized, must include, at least, the following information:

  1. First name(s) and surname(s) of the holder;
     
  2. Date of birth;
     
  3. Disease or agent from which the holder has recovered: COVID-19 (SARS-CoV-2 or one of its variants);
     
  4. Date of the first positive result of the diagnostic test;
     
  5. Member State or third country in which the diagnostic test was carried out;
     
  6. The entity issuing the certificate; g) Certificate valid since.
     

2.5. Vaccination certificates shall only be recognized as valid if their holders have been inoculated with the following vaccines against COVID-19:

  1. Janssen: COVID-19 Vaccine Janssen (also known as Ad26.COV2);
  2. AstraZeneca: Vaxzevria (also known as AZD1222, COVID-19 Vaccine AstraZeneca, Covishield, and R-COVI);
  3. Moderna: Spikevax (also known as mRNA-1273 and COVID-19 Vaccine Moderna);
  4. Pfizer-BioNTech: Comirnaty (also known as BNT162b2, Tozinameran (INN), Pfizer-BioNTech COVID-19 mRNA vaccine, and Pfizer COVID-19 Vaccine);
  5. Serum Institute of India: Nuvaxovid (also known as Covovax);
  6. Sinopharm: BBIBP-CorV;
  7. Sinovac: CoronaVac / PiCoVacc;
  8. Bharat Biotech: COVAXIN.
     

2.6. Vaccination or recovery certificates issued by third countries, under reciprocity conditions, will only be recognized as valid when they include the data fields listed in items 2.3 and 2.4..
 

2.7. The non-reciprocity in the recognition by third countries of the validity of the EU COVID Digital Certificate, in the modalities of vaccination and recovery certificates, issued by Portugal, prevents the validity recognition of certificates issued by these third countries.
 

2.8. Minors traveling with one or both parents or any other responsible companion are exempt from quarantine if the companions hold a valid vaccination or recovery certificate when entering the national territory.
 

For more information about the vaccination or recovery certificates, please refer to Decree-Law no. 54-A/2021 of June 25, as amended by Decree-Law no. 22/2022 of February 6.

 

3. The use of masks is mandatory for all passengers older than 10 years of age inside airports, aircraft, and buses.

 

These measures regarding air traffic and airports do not apply to:

  • Flights by State and Armed Forces aircraft;
  • Flights of aircraft that are or will be part of the Special Division to Fight Rural Fire;
  • Flights for the exclusive transport of cargo and mail;
  • Flights for humanitarian or medical emergency purposes;
  • Flights for medical emergency purposes;
  • Flights of technical stopovers for non-commercial purposes.
     

 

These guidelines do not exempt the careful reading of article 6 of the Council of Ministers Resolution No. 41-A/2022 of April 21, 2022 and Order 4829-A/2022 of April 22, 20222.


This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.
Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

Top

 

 

1. Mandatory information that passengers must provide


1.1. Unvaccinated foreign passengers will not be permitted to enter Canada unless they meet one of the few exemptions.
Check here if you qualify for the exemptions.

 

1.2. All passengers five years of age or oldermust provide proof of one of the following accepted types of test results:

  • Proof of a COVID-19 negative molecular test result, performed by one of the accepted methodologies, within 72 hours of the scheduled departure time of the flight to Canada; or
  • Proof of a negative result from a professionally administered or observed antigen test taken outside of Canada no more than 1 day before the scheduled flight to Canada; or
  • Proof of a previous positive test result taken between 10 and 180 days. Counting starts the day after the test.
     

1.2.1. Exceptions:

  • Passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days before arrival. The certificate must be in English, French, or accompanied by a certified English or French translation.
  • Passengers with proof of positive COVID-19 molecular test result taken between 10 and 180 days before departure of the last direct flight to Canada. Counting begins the day after the test.
     

1.2.2. Molecular tests accepted: CRISPR, Ct, detection of the E gene, detection of the N gene, detection of Orf1a/b, detection of the RdRp gene, detection of the S gene, ddPCR, isothermal amplification, LamPORE, NAAT, NAT, NGS, PCR, qPCR, RNA, RT-LAMP, RT-PCR, sequencing, and WGS.
 

1.2.3. The antigen test must be administered or observed by a laboratory or testing provider. Phrases indicating a test is an antigen test could include, but is not limited to:

  • rapid antigen test
  • viral antigen test
  • diagnostic immunoassay
  • lateral flow test (LFT)
  • also could be noted as an Antigen Chromatographic Digital Immunoassay, Antigen Chemiluminescence Immunoassay, or Antigen Lateral Flow Fluorescence
     

1.2.4. The documentation of the negative laboratory COVID-19 test result must include the following data elements:

  1. the person’s name and date of birth;
  2. the name and civic address of the laboratory that administered the test;
  3. the date the specimen was collected, and the test method used; and
  4. the test result.

 

If passengers have a connecting flight:

  • the test must be conducted within 72 hours of the scheduled departure time of the last direct flight to Canada;
  • passenger may need to schedule the test in the transit city.

 

If passengers have already had COVID-19 and recovered

If now symptom-free, passengers can provide proof of a positive COVID-19 molecular test, instead of a negative one.
This test result will also exempt passengers from the requirement for an arrival test, and from a Day-8 test for those required to quarantine.

  • The test must have been conducted at least 10 and no more than 180 days before the passengers’ initial scheduled departure time of the flight;
  • The proof of the positive result must be from an accepted type of molecular test.
     

Passengers must:

  • provide one of the accepted types of tests;
  • keep proof of the test results for the 14-day period that begins on the day they enter Canada.

 

1.3. When entering Canada, passengers five years of age and older will be subject to take an arrival COVID-19 test before exiting the airport.

For a quicker testing experience upon arrival in Toronto, avoiding lengthy lines and delays in processing, passengers must pre-register before they arrive in Toronto at portal.switchhealth.ca. Passengers should use the same e-mail address they used for their ArriveCAN account.

There is no fee for the arrival test.

 

1.3.1. Unvaccinated passengers eligible to enter Canada are required to test on arrival, on Day 8 and quarantine for 14 days. They must remain in quarantine until the expiry of the 14-day period that begins on the day on which they enter Canada, or until receipt of a negative test result from the arrival COVID-19 molecular test, whichever comes first.
 

1.3.2. Fully vaccinated passengers will be randomly selected for arrival testing and won’t be required to quarantine while awaiting their test result.
 

You can find more information here.

 

1.4. All passengers traveling to Canada, regardless of nationality or citizenship, must, before boarding a flight to the country, submit their travel details, contact information, vaccination information, pre-entry test results, and quarantine plan digitally through the ArriveCAN mobile application, available at the Apple App Store and Google Play, or the website, within 72 hours before their arrival to Canada.
 

Passengers who do not submit the required information through ArriveCAN may be denied boarding.
 

Canadian citizens, permanent residents or persons registered under the Indian Act and foreign nationals eligible to enter Canada under another entry exemption (such as foreign work, study, compassionate grounds) will not be denied boarding or entry, but they:

  • won't be eligible for the fully vaccinated traveler exemption;
  • may face additional delays for public health questioning;
  • may be subject to fines or enforcement action.

 

For more information, or if you require assistance, visit Canada.ca/ArriveCAN.
 

1.5. Before boarding an aircraft for a flight to Canada, all passengers must complete a health check by submitting a questionnaire and consent forms.

1.5.1. Every passenger must confirm to the airline that they understand they may be subject to measures to prevent the spread of COVID-19 defined by the federal, provincial, or territorial governments on arrival at their destination.
 

1.5.2. Foreign nationals must confirm to the airline that, to the best of their knowledge, they are not prohibited from entering Canada in compliance with an order made under section 58 of the Quarantine Act.
 

1.5.3. A competent adult may provide the confirmations on behalf of a person who does not have the ability or competence to do so.
 

1.5.4. Passengers may be liable to a monetary penalty, up to $5,000, if they provide answers concerning the health check or confirmations that they know to be false or misleading.

 


Do not forget that to enter Canada, you must present a valid visa exemption. Therefore, you must apply for a Travel Authorization at least 72 hours before your departure. You can do it electronically here.


 

2. Restrictions and prevention measures applied by the authorities
 

2.1. Passengers must have a COVID-19 vaccination certificate uploaded in ArriveCAN showing that they were fully vaccinated at least 15 days (day of vaccination + 14 days) before arrival. The certificate must be in English, French, or accompanied by a certified English or French translation.
Vaccines accepted are AstraZeneca (Covishield), AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covaxin, Covovax, Janssen, Moderna (Spikevax), Nuvaxovid (Novavax), Pfizer-BioNTech (Comirnaty), Sinopharm, or Sinovac. A combination of vaccines is accepted.
This does not apply to:

  • Nationals of Canada;
  • Permanent residents of Canada;
  • Persons registered under the Canada’s Indian Act with the Certificate of Indian Status (CIS) or the Secure Certificate of Indian Status (SCIS);
  • Passengers with an authorization from the Public Health Agency of Canada (PHAC) for compassionate entry;
  • Passengers with a Canadian Refugee Travel Document or a Single Journey Document for Resettlement to Canada;
  • Passengers younger than 18 years traveling with their vaccinated parents or guardians;
  • Passengers with an application for permanent residence. They must have a written notice issued under the Immigration and Refugee Protection Act;
  • Nationals of Ukraine and their immediate family members with a Canadian Temporary Resident Permit or a Canadian Temporary Resident Visa.

 

2.2. Passengers must have:

  • a negative molecular COVID-19 test taken outside of Canada at most 72 hours before departure of the last direct flight to Canada.
    Tests accepted: CRISPR, Ct, detection of the E gene, detection of the N gene, detection of Orf1a/b, detection of the RdRp gene, detection of the S gene, ddPCR, isothermal amplification, LamPORE, NAAT, NAT, NGS, PCR, qPCR, RNA, RT-LAMP, RT-PCR, sequencing, and WGS; or
  • a negative COVID-19 antigen test taken at most one day before departure of the last direct flight to Canada.
This does not apply to:
  • Passengers younger than 5 years;
  • Passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days before arrival. The certificate must be in English, French, or accompanied by a certified English or French translation. Vaccines accepted are AstraZeneca (Covishield), AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covaxin, Covovax, Janssen, Moderna (Spikevax), Nuvaxovid (Novavax), Pfizer-BioNTech (Comirnaty), Sinopharm, or Sinovac. A combination of vaccines is accepted.
  • Passengers with a positive molecular COVID-19 test taken at least 10 days and at most 180 days before departure of the last direct flight to Canada. Tests accepted: CRISPR, Ct, detection of the E gene, detection of the N gene, detection of Orf1a/b, detection of the RdRp gene, detection of the S gene, ddPCR, isothermal amplification, LamPORE, NAAT, NAT, NGS, PCR, qPCR, RNA, RT-LAMP, RT-PCR, sequencing, and WGS.

More details can be found here.

 

2.3. Passengers must submit their information electronically, at most 72 hours before arrival, through the ArriveCAN app or the website. Passengers must present an ArriveCAN receipt before boarding.

 

2.4. Passengers could be subject to quarantine for 14 days.

This does not apply to:

  • Passengers younger than 12 years traveling with their vaccinated parents or guardians;
  • Passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days before arrival. The certificate must be in English or French or be accompanied by a certified translation to English or French. Vaccines accepted are AstraZeneca (Covishield), AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covaxin, Covovax, Janssen, Moderna (Spikevax), Nuvaxovid (Novavax), Pfizer-BioNTech (Comirnaty), Sinopharm, or Sinovac. A combination of vaccines is accepted.

 

More details can be found here.

 

2.5. Passengers five years of age or older are subject to a COVID-19 molecular test upon arrival.

  • More details for vaccinated passengers here.
  • More details for unvaccinated passengers here.

 

2.6. Passengers aged 2 years old or older must always wear a face mask or cover during the boarding process, in-flight, when exiting the aircraft, and when directed to do so by a gate agent, airport security screening personnel, or a crew member, and when traveling through Canadian airports. Check which masks or facial covers are accepted and allowed by the Canadian authorities here.

  • Children under the age of 2 are not required to wear a non-medical mask or face covering.
  • Between the ages of 2 and 5 years, children are required to wear a non-medical mask or face covering at the time of boarding, during flight, and while disembarking, so long as the child can tolerate it. Children of these ages (or their parents/guardians) must be able to demonstrate they have a mask in their possession when boarding the aircraft, even if the child cannot tolerate wearing it at that time.
  • Children six and older must wear a non-medical mask or face covering when traveling unless their parent or guardian has a medical certificate.

 

2.7. Passengers may be denied boarding on flights to Canada if:

  • they exhibit a fever and a cough, or a fever and breathing difficulties;
  • they have COVID-19, or they have had it within the previous 10 days, or they have reasonable grounds to suspect that they have COVID-19 or have developed signs and symptoms of COVID-19 within the previous 10 days; or
  • in the case of a flight departing from Canada, they are the subject of a mandatory quarantine order resulting from recent travel or from a local or provincial public health order.

 

This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.

Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

Top

 

COVID-19 screening test with negative result Mandatory
Completion of a questionnaire with health and travel information Mandatory
Need for prophylactic isolation / quarantine Subject to measures set by the state or territory of destination.

 

Mandatory information that passengers must provide

 

1. All passengers 18 years of age or older non-US citizens, non-US nationals, not legal permanent residents of the US, or traveling to the United States on a non-US immigrant visa, must show proof of being fully vaccinated against COVID-19 before traveling to the United States from a foreign country. Only limited exceptions apply. Learn more about this requirement here.
 

2. All passengers 2 years of age and older, regardless of their vaccination status, nationality, or citizenship, must present a document proving a negative COVID-19 screening test result taken no more than 1 day before travel, which may be an antigen test or a nucleic acid amplification test (NAAT), such as RT-PCR, RT-LAMP, TMA, as approved by the competent national authority in the country where the test is administered, to the airline before boarding a flight to the United States from a foreign country. Otherwise, boarding or entry into the country will be denied.
 

3. Passengers who have recently recovered from COVID-19 will be permitted to travel upon presentation of proof of recovery from COVID-19, which includes a positive result from a COIVID-19 screening test performed on a sample collected within 10 to 90 days before departure of the flight to the United States of America, and a signed statement on official letterhead containing the name, address, and telephone number of licensed health care professional or public health authority attesting that the passenger is cleared for travel.
 

4. All passengers with 2 years old or older, regardless of nationality or citizenship, must complete and print the following attestation form before departure, which must be given to the airline when boarding the flight to the United States of America.
 

5. Upon arrival in the United States, public health officials may randomly check the passengers’ COVID-19-related documentation that they were required to show before boarding the flight, which may include the passengers’ COVID-19 test results or documentation of recovery from COVID-19 and proof of COVID-19 vaccination, if applicable.
 

5.1. Every passenger aged 2 years and older may be required to present this documentation, and they must have it, along with their passport, available for inspection.
 

5.2. If the passenger’s proof of COVID-19 vaccination, COVID-19 test result, or your documentation of recovery is digital and on a mobile device, passengers must preload this information or have a screen capture or picture of the documentation on their mobile device for inspection by the public health officials.

 

Further information and clarifications can be found here.

Check here if you can board a flight to the United States.


Do not forget that you must present a valid visa exemption to enter the United States of America. Therefore, you must apply for a Travel Authorization at least 72 hours before your departure. You can do it electronically here.
 

 

Restrictions and prevention measures applied by the authorities

1. Passengers entering or transiting through the USA must have a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days (day of vaccination + 14 days) before arrival. Passengers’ details (e.g., name and date of birth) in the certificate must match those stated in the passport/travel document. Vaccines accepted are:

  • AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covaxin, Covishield, Covovax, Janssen, Moderna (Spikevax), Nuvaxovid (Novavax), Pfizer-BioNTech (Comirnaty), Sinopharm (BIBP), and Sinovac. A combination of these vaccines is accepted if administered at least 17 days apart.

    This does not apply to:
    • Nationals of the USA;
    • Residents of the USA;
    • Passengers younger than 18;
    • Passengers with a letter issued by a doctor proving that the passenger is medically unable to receive the vaccine;
    • Passengers with the following visas: A-1, A-2, C-2, C-3 (as a foreign government official or immediate family member of an official), E-1 (as an employee of TECRO or TECO or the employee’s immediate family members), G-1, G-2, G-3, G-4, NATO-1 through NATO-4, or NATO-6 (or seeking to enter as a nonimmigrant in one of those NATO classifications);
    • Passengers with a letter of invitation or other official document, issued by the USA, by other government or by the United Nations, traveling on duty;
    • Nationals of Afghanistan. Algeria, Angola, Armenia, Benin, Burkina Faso, Burundi, Cameroon, Central African Rep., Chad, Congo, Congo (Dem. Rep.), Cote d’Ivoire, Djibouti, Egypt, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Haiti, Iraq, Kenya, Kiribati, Liberia, Libya, Madagascar, Malawi, Mali, Mozambique, Myanmar, Namibia, Nicaragua, Niger, Nigeria, Papua New Guinea, Senegal, Sierra Leone, Solomon Isl., Somalia, South Sudan, Syria, Tanzania, Togo, Uganda, Vanuatu, Yemen, and Zambia, with a visa issued by the USA, excluding B-1 and B-2 visas;
    • Members of the U.S. Armed Forces, their spouses, and children younger than 18 years;
    • Merchant seamen with a C, D, C1/D, B1, H, or L visas;
       

More details can be found here.

 

2. Passengers entering or transiting through the USA must have a negative COVID-19 test taken at most 1 day before departure from the first embarkation point. Tests accepted are antigen, NAAT, RT-LAMP, RT-PCR, or TMA. Passengers’ details (e.g., name and date of birth) in the test must match those stated in the passport or other travel document; and the test result must specify “negative” or “not detected”. If marked “invalid” it is not accepted.

This does not apply to:

  • Passengers younger than 2 years;
  • US military personnel;
  • Passengers with a positive COVID-19 test taken at least 10 and at most 90 days before departure from the first embarkation point and a letter issued by a health authority stating that the passenger has been cleared for travel.

 

3. Passengers could be subject to self-isolation or self-quarantine for a full 7 days.
This does not apply to:

  • Passengers with a COVID-19 recovery certificate proving recovery in the past 90 days;
  • Passengers with a COVID-19 vaccination certificate showing that they were fully vaccinated at least 15 days (day of vaccination + 14 days) before arrival. Passengers’ details (e.g., name and date of birth) in the certificate must match those stated in the passport/travel document.
    Vaccines accepted are:
    • AstraZeneca (SK Bioscience), AstraZeneca (Vaxzevria), Covaxin, Covishield, Covovax, Janssen, Moderna (Spikevax), Nuvaxovid (Novavax), Pfizer-BioNTech (Comirnaty), Sinopharm (BIBP), and Sinovac. A combination of these vaccines is accepted if administered at least 17 days apart.

More details can be found here.

 

4. Passengers aged 2 years or older should properly wear a well-fitting mask or respirator in indoor areas of public transportation (which includes airplanes and buses) and transportation hubs (including airports), especially in locations that are crowded or poorly ventilated, such as airport jetways.

 

5. Passengers are subject to COVID-19 measures set by the state or territory of their final destination. More information aqui.

 

6. International travelers arriving in the United States are recommended to get a SARS-CoV-2 viral test 3-5 days after travel, regardless of vaccination status.

 

7. Nationals of the USA are allowed to enter with an expired passport. This does not apply to emergency passports which must be valid on arrival.

 

8. DV visas issued in September 2020 that expired are accepted for entry.


This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.
Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

You can also find more relevant information here.

 

Top

 

You can find updated information on the Official Entities' website here.

 

Top

 

Mandatory information that passengers must provides

Passengers must complete online the surveillance and health control form.


Before departure, incoming travelers must register at the online electronic platform EASE. Registration shall be preferably done five days before the travel date, and it consists of the submission of passport details and other relevant information such as arrival and departure dates, flight number, and place of accommodation.

 

Restrictions and prevention measures applied by the authorities

1. Passengers on international travel to Cape Verde are required to submit, before boarding, under penalty of being denied boarding or entry into the country:

  1. A valid COVID-19 vaccination certificate showing complete vaccination or with a booster dose, issued at least 14 days before arrival; or
     
  2. A negative COVID-19 screening antigen test performed within 48 hours before departure from the first boarding point; or
     
  3. A negative COVID-19 screening RT-PCR test performed within 72 hours before departure from the first boarding point; or
     
  4. A valid COVID-19 recovery certificate issued no more than 90 days before arrival.
     

Exceptions:

  1. Children up to 12 years old.
     
  2. Passengers in transit, stopover, or transfer, provided they do not cross the national border, without prejudice to compliance with the other measures determined by the health authorities.

 

2. Upon arrival in Cape Verde, passengers may be subjected to health screening.

 

You can find more information here.

 

This information is summarized and constantly updated, not exempting the full reading of the Official Entities' website here.

Please be advised that it is the passenger's sole responsibility to verify the necessary documentation and/or requirements and current COVID-19 restrictions in all countries of the itinerary, effective on the date of travel.

 

Top

 

You can find updated information on the Official Entities' website here.

 

Top

Loading...